New hope for tough cancers: early trial tests promising drug combo
Disease control
Not yet recruiting
This early-stage study is testing the safety and initial effectiveness of a new drug called BC3195 when given alongside an existing immunotherapy (pembrolizumab). It is for adults with advanced solid tumors, like certain lung, breast, and head/neck cancers, that have spread or ca…
Phase: PHASE1, PHASE2 • Sponsor: Biocity Biopharmaceutics Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC